Abstract
Backgrounds Fabry disease (FD) is an X-linked lysosomal disorder with ventricular myocardial involvement that drives morbidity and mortality. Early diagnosis of cardiac involvement can be difficult. This study explored whether abnormal left atrial (LA) strain by cardiovascular magnetic resonance (CMR) may be an early sign of ventricular involvement in FD.
Methods A multicenter, multinational cohort of FD patients was assembled with images centralized for corelab analysis. Adult gene-positive FD patients and healthy volunteers (HV) underwent CMR. LA strain analyses included manually contouring the LA in end-diastole and end-systole to calculate LA volumes and ejection fraction, then semi-automatic analysis for LA reservoir strain.
Results There were n=214 FD patients (mean age 45±15 years, 39% males) and n=76 HV (49±15 years, 53% males). CMR results in FD: LVEF 73% (IQR=9), LV mass indexed (LVMi) 89±39g/m2, 99 (46%) had left ventricular hypertrophy (LVH), 36% had late gadolinium enhancement. In FD, LA strain correlated with LVMi (r=-0.52, p<0.01), LV global longitudinal strain (GLS) (r=-0.61,p<0.01), and native myocardial T1 (r=0.34, p<0.01). FD had abnormal LA strain in overt disease (LVH +ve) compared to HVs (p<0.01). LVH-negative FD did not differ in LA strain compared with HV (p>0.5). FD with low T1+LVH-negative did not differ in LA strain compared with normal T1/LVH-negative FD or HV (p>0.3).
Conclusions LA strain is abnormal in FD with LVH (overt disease) and correlates with LVMi, native T1, and GLS. LA strain is normal in FD with early disease (LVH negative+low T1) and normal in FD with no myocardial disease (LVH negative + normal T1). These findings indicate that LA strain is a consequence of abnormal LV mechanics such as LVH and abnormal GLS, rather than isolated myocardial sphingolipid deposition.
What is already known on this topic Fabry disease is an X-linked lysosomal disorder with potential cardiac complications. Progressive ventricular myocardial involvement drives morbidity and mortality and can be detectable through advanced imaging techniques like cardiovascular magnetic resonance. Early diagnosis of cardiac involvement can be difficult.
What this study adds LA strain is abnormal in overt Fabry disease with left ventricular hypertrophy (LVH) and correlates with left ventricular mass, native T1, and global longitudinal strain (GLS). LA strain is normal in Fabry with early disease (LVH negative+low T1) and normal in FD with no myocardial disease (LVH negative + normal T1). These findings indicate that LA strain is a consequence of abnormal LV mechanics such as LVH and abnormal GLS, rather than isolated myocardial sphingolipid deposition.
How this study might affect research There is a need to identify markers of early cardiac involvement in Fabry disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded in part an investigator-led research grant from Sanofi-Genzyme. The authors or their institutions at any time received payment or services from a third party for any aspect of the submitted work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the relevant local Research Ethics Committees (Northern Sydney Local health District Human Research Ethics Committee), and written informed consent was obtained from all participants.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Declaration of Conflict of Interest The authors declare no conflicts of interest in preparing this article.
Data Availability
All data produced in the present work are contained in the manuscript.
ABBRIEVIATIONS LIST
- CMR
- cardiovascular magnetic resonance
- FD
- Fabry disease
- GLS
- global longitudinal strain
- HV
- healthy volunteers
- LA
- left atrium
- LGE
- late gadolinium enhancement
- LVMi
- left ventricular mass index
- LVH
- left ventricular hypertrophy
- LV
- left ventricle
- LVEF
- left ventricular ejection fraction
